Dynadis Biotech India Profile
Key Indicators
- Authorised Capital ₹ 1.90 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.88 Cr
as on 17-11-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 19.01 Cr
as on 17-11-2024
- Revenue -5.83%
(FY 2023)
- Profit -26.39%
(FY 2023)
- Ebitda -18.64%
(FY 2023)
- Net Worth 16.09%
(FY 2023)
- Total Assets -24.24%
(FY 2023)
About Dynadis Biotech India
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.90 Cr and a paid-up capital of Rs 1.88 Cr.
The company has closed loans amounting to ₹19.01 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kodimule Shyamprasad and Veena Shyamprasad serve as directors at the Company.
- CIN/LLPIN
U01403PY2009PTC002376
- Company No.
002376
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2009
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Company Details
- Location
Pondicherry, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dynadis Biotech India?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kodimule Shyamprasad | Nominee Director | 07-Jun-2014 | Current |
Veena Shyamprasad | Nominee Director | 07-Jun-2014 | Current |
Financial Performance and Corporate Structure Insights of Dynadis Biotech India.
Dynadis Biotech India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.83% decrease. The company also saw a substantial fall in profitability, with a 26.39% decrease in profit. The company's net worth Soared by an impressive increase of 16.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Dynadis Biotech India?
In 2023, Dynadis Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Manko Natural Flavours And Extracts Private LimitedActive 20 years 10 months
Kodimule Shyamprasad and Veena Shyamprasad are mutual person
- Vidya Herbs Private LimitedActive 20 years 7 months
Kodimule Shyamprasad and Veena Shyamprasad are mutual person
- Vidyanutra Commodities Private LimitedActive 1 year 4 months
Kodimule Shyamprasad and Veena Shyamprasad are mutual person
- Vinaya Hotels And Leisures Private LimitedActive 12 years 8 months
Kodimule Shyamprasad and Veena Shyamprasad are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Citi Bank N.A. Creation Date: 26 Nov 2019 | ₹3.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 10 May 2018 | ₹16.01 Cr | Satisfied |
How Many Employees Work at Dynadis Biotech India?
Dynadis Biotech India has a workforce of 16 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dynadis Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dynadis Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.